{
    "medicine_id": "ccb2ff6e6589cb90df6c3d0cda9c26dfc3c5442f",
    "platform_id": "DB04863",
    "metadata": {
        "name": "Bystolic 5 mg 1 Tablet",
        "composition": "5 mg 1 Lefradafiban",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of unstable angina",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Lefradafiban an orally active prodrug of fradafiban is a novel glycoprotein IIb IIIa inhibitor for the treatment of unstable angina Development was discontinued in 2000 due to lack of efficacy",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB13967",
                        "description": "The therapeutic efficacy of Lefradafiban can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Lefradafiban may increase the vasodilatory activities of Isosorbide mononitrate"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}